Pharmaceuticals
Regarding the use of abuse-deterrent medications to reduce prescription and over the counter drug abuse of opioids and pseudophaedrine products;  Regarding the definition of "relevant routes of abuse" in the Food and Drug Administration's Draft Abuse-Deterrent Opioid Guidance
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AVANCER HEALTH POLICY
2003 Paul Spring Road, Alexandria, VA, 22307, US
CHRISTOPHER KOPPEN (Legislative Assistant, Office of Charlie Norwood)
Legislative Assistant, Office of Charlie Norwood